|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents (Note 13) | ||||||||||||||||||||
| Restricted cash and cash equivalents (Note 10) | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Taxes receivable (Note 4) | ||||||||||||||||||||
| Derivatives (Note 12) | ||||||||||||||||||||
| Other current assets (Note 13) | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Oil and Gas Properties | ||||||||||||||||||||
| Proved | ||||||||||||||||||||
| Unproved | ||||||||||||||||||||
| Total Oil and Gas Properties | ||||||||||||||||||||
| Other capital assets | ||||||||||||||||||||
| Total Property, Plant and Equipment | ||||||||||||||||||||
| Other Long-Term Assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Taxes receivable long-term (Note 4) | ||||||||||||||||||||
| Restricted cash and cash equivalents (Note 13) | ||||||||||||||||||||
| Other long-term assets (Note 12 and 13) | ||||||||||||||||||||
| Total Other Long-Term Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable, accrued liabilities and other (Note 6 and 7) | ||||||||||||||||||||
| Credit facility (Note 10) | ||||||||||||||||||||
| Current portion of long-term debt (Note 6 and 12) | ||||||||||||||||||||
| Taxes payable (Note 4) | ||||||||||||||||||||
| Derivatives (Note 12) | ||||||||||||||||||||
| Equity compensation award liability (Note 8) | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-Term Liabilities | ||||||||||||||||||||
| Long-term debt (Note 6 and 12) | ||||||||||||||||||||
| Customer advance (Note 7) | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Asset retirement obligation | ||||||||||||||||||||
| Equity compensation award liabilities (Note 13) | ||||||||||||||||||||
| Taxes payable (Note 5) | ||||||||||||||||||||
| Equity compensation award liability (Note 8) | ||||||||||||||||||||
| Other long-term liabilities (Note 4) | ||||||||||||||||||||
| Total Long-Term Liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common Stock (35,380,429 and 35,298,774 issued and outstanding shares of Common Stock as at June 30, 2026 and December 31, 2025, respectively, par value $0.001 per share), (Note 8) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock (Note 13) | ||||||||||||||||||||
| Accumulated other comprehensive (loss) gain | ||||||||||||||||||||
| Deficit | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Shares issued and outstanding, as at end of period (in shares) | ||||||||||||||||||||
Loading...
